Inhibition of Amyloid-ß and a-Synuclein Oligomer-induced NLRP3 Inflammasome Activation by NDGA in Microglia: A Promising Anti-inflammatory Strategy for Neurodegeneration

Characterization of "Early-Start" Participants that Continued Receiving Donanemab in the TRAILBLAZER-ALZ 2 Long-Term Extension Period